| __timestamp | Dr. Reddy's Laboratories Limited | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 179279000 |
| Thursday, January 1, 2015 | 62786000000 | 186359000 |
| Friday, January 1, 2016 | 62427000000 | 171785000 |
| Sunday, January 1, 2017 | 62453000000 | 208136000 |
| Monday, January 1, 2018 | 65724000000 | 198405000 |
| Tuesday, January 1, 2019 | 70421000000 | 224169000 |
| Wednesday, January 1, 2020 | 80591000000 | 245044000 |
| Friday, January 1, 2021 | 86645000000 | 252314000 |
| Saturday, January 1, 2022 | 100551000000 | 268225000 |
| Sunday, January 1, 2023 | 42907000000 | 304629000 |
| Monday, January 1, 2024 | 115557000000 | 324203000 |
Data in motion
In the competitive landscape of pharmaceuticals, Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd. have showcased intriguing cost of revenue trends over the past decade. From 2014 to 2024, Dr. Reddy's Laboratories experienced a significant 105% increase in cost of revenue, peaking in 2024. This reflects their aggressive expansion and market penetration strategies. In contrast, Taro Pharmaceutical Industries Ltd. maintained a more stable trajectory, with a modest 81% rise over the same period, indicating a focus on efficiency and cost management.
The year 2023 marked a notable divergence, with Dr. Reddy's costs dropping by 57%, while Taro's costs surged by 14%. This shift could signal strategic pivots or market responses to external pressures. As these companies navigate the ever-evolving pharmaceutical industry, their cost management strategies will be crucial in determining their future market positions.
Analyzing Cost of Revenue: Novartis AG and Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Grifols, S.A.
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored